Evidence map›Paper›PMID 36880031›Full record

ArticleBalkan journal of medical genetics : BJMG2022

A Novel

Y Peng, J Xu, Y Wang, J Zhao, L Zhang, Z Chen, Y Jiang, S Banerjee, Z Zhang, M Bai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 67% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Y PengDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
J XuDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
Y WangDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
J ZhaoDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
L ZhangDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
Z ChenDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
Y JiangDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
S BanerjeeDepartment of Genetics, College of Basic Medical Sciences, Jilin University, Changchun, Jilin 130021, China.
Z ZhangDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
M BaiDepartment of Cardiology, the First Hospital of Lanzhou University, Lanzhou, China.
Gansu Provincial Hospital · CNFirst Hospital of Lanzhou University · CNGansu Provincial Center for Disease Control and Prevention · CNLanzhou University · CNJilin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiomyopathies are a heterogeneous group of diseases predominantly affecting the heart muscle and often lead to progressive heart failure-related disability or cardiovascular death. Hypertrophic cardiomyopathy (HCM) is a cardiac muscle disorder mostly caused by the mutations in genes encoding cardiac sarcomere. Germ-line mutations in

Indexed as

familial hypertrophic cardiomyopathyheterozygousloss-of-function.MYBPC3 genenovel variant

Identifiers

PMID36880031
PMCPMC9985356
OpenAlexW4322711857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.